Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8879 |
High Similarity |
NPD2342 |
Discontinued |
0.8684 |
High Similarity |
NPD3091 |
Approved |
0.8649 |
High Similarity |
NPD7635 |
Approved |
0.8641 |
High Similarity |
NPD1809 |
Phase 2 |
0.8558 |
High Similarity |
NPD288 |
Approved |
0.8534 |
High Similarity |
NPD4059 |
Approved |
0.8534 |
High Similarity |
NPD3019 |
Approved |
0.8462 |
Intermediate Similarity |
NPD844 |
Approved |
0.8396 |
Intermediate Similarity |
NPD3020 |
Approved |
0.839 |
Intermediate Similarity |
NPD3092 |
Approved |
0.8376 |
Intermediate Similarity |
NPD2932 |
Approved |
0.8365 |
Intermediate Similarity |
NPD1432 |
Clinical (unspecified phase) |
0.8269 |
Intermediate Similarity |
NPD845 |
Approved |
0.822 |
Intermediate Similarity |
NPD3095 |
Discontinued |
0.8214 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.8148 |
Intermediate Similarity |
NPD289 |
Clinical (unspecified phase) |
0.8136 |
Intermediate Similarity |
NPD4093 |
Discontinued |
0.8115 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.8113 |
Intermediate Similarity |
NPD2859 |
Approved |
0.8113 |
Intermediate Similarity |
NPD2860 |
Approved |
0.8067 |
Intermediate Similarity |
NPD1751 |
Approved |
0.8067 |
Intermediate Similarity |
NPD2286 |
Discontinued |
0.8053 |
Intermediate Similarity |
NPD3021 |
Approved |
0.8053 |
Intermediate Similarity |
NPD3022 |
Approved |
0.8019 |
Intermediate Similarity |
NPD2934 |
Approved |
0.8019 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7984 |
Intermediate Similarity |
NPD5736 |
Approved |
0.7969 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7951 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.792 |
Intermediate Similarity |
NPD2606 |
Approved |
0.792 |
Intermediate Similarity |
NPD2605 |
Approved |
0.7857 |
Intermediate Similarity |
NPD5156 |
Approved |
0.7857 |
Intermediate Similarity |
NPD5155 |
Approved |
0.7851 |
Intermediate Similarity |
NPD3026 |
Approved |
0.7851 |
Intermediate Similarity |
NPD3023 |
Approved |
0.784 |
Intermediate Similarity |
NPD3635 |
Approved |
0.784 |
Intermediate Similarity |
NPD3637 |
Approved |
0.784 |
Intermediate Similarity |
NPD3636 |
Approved |
0.7833 |
Intermediate Similarity |
NPD3025 |
Approved |
0.7833 |
Intermediate Similarity |
NPD3024 |
Approved |
0.7778 |
Intermediate Similarity |
NPD3595 |
Approved |
0.7778 |
Intermediate Similarity |
NPD3594 |
Approved |
0.7769 |
Intermediate Similarity |
NPD4589 |
Approved |
0.7769 |
Intermediate Similarity |
NPD4626 |
Approved |
0.776 |
Intermediate Similarity |
NPD4624 |
Approved |
0.776 |
Intermediate Similarity |
NPD2195 |
Approved |
0.776 |
Intermediate Similarity |
NPD2194 |
Approved |
0.7759 |
Intermediate Similarity |
NPD6124 |
Clinical (unspecified phase) |
0.7739 |
Intermediate Similarity |
NPD1792 |
Phase 2 |
0.7734 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7731 |
Intermediate Similarity |
NPD7325 |
Clinical (unspecified phase) |
0.7674 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7674 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7627 |
Intermediate Similarity |
NPD7159 |
Clinical (unspecified phase) |
0.7603 |
Intermediate Similarity |
NPD5304 |
Approved |
0.7603 |
Intermediate Similarity |
NPD5303 |
Approved |
0.76 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7589 |
Intermediate Similarity |
NPD846 |
Approved |
0.7589 |
Intermediate Similarity |
NPD940 |
Approved |
0.7578 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7563 |
Intermediate Similarity |
NPD497 |
Approved |
0.7522 |
Intermediate Similarity |
NPD5700 |
Clinical (unspecified phase) |
0.752 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD111 |
Approved |
0.75 |
Intermediate Similarity |
NPD1201 |
Approved |
0.748 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7479 |
Intermediate Similarity |
NPD2229 |
Approved |
0.7479 |
Intermediate Similarity |
NPD495 |
Approved |
0.7479 |
Intermediate Similarity |
NPD2234 |
Approved |
0.7479 |
Intermediate Similarity |
NPD498 |
Approved |
0.7479 |
Intermediate Similarity |
NPD2228 |
Approved |
0.7479 |
Intermediate Similarity |
NPD496 |
Approved |
0.7478 |
Intermediate Similarity |
NPD1444 |
Approved |
0.7478 |
Intermediate Similarity |
NPD1445 |
Approved |
0.7459 |
Intermediate Similarity |
NPD2226 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD7742 |
Approved |
0.7444 |
Intermediate Similarity |
NPD7743 |
Approved |
0.7438 |
Intermediate Similarity |
NPD7340 |
Approved |
0.7405 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7405 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7402 |
Intermediate Similarity |
NPD4339 |
Clinical (unspecified phase) |
0.7398 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7385 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD4749 |
Approved |
0.736 |
Intermediate Similarity |
NPD5351 |
Clinical (unspecified phase) |
0.736 |
Intermediate Similarity |
NPD5350 |
Clinical (unspecified phase) |
0.7348 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7345 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7333 |
Intermediate Similarity |
NPD4869 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD4725 |
Approved |
0.7333 |
Intermediate Similarity |
NPD4721 |
Approved |
0.7333 |
Intermediate Similarity |
NPD1398 |
Phase 1 |
0.7333 |
Intermediate Similarity |
NPD4726 |
Approved |
0.7323 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7317 |
Intermediate Similarity |
NPD7330 |
Discontinued |
0.7313 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7293 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7266 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7259 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7259 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7259 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7259 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7258 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7258 |
Intermediate Similarity |
NPD4235 |
Clinical (unspecified phase) |
0.7258 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7252 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD7718 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD3638 |
Discontinued |
0.7217 |
Intermediate Similarity |
NPD9500 |
Approved |
0.7213 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7185 |
Intermediate Similarity |
NPD3299 |
Clinical (unspecified phase) |
0.7154 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD2688 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD3143 |
Discontinued |
0.7132 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7132 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7131 |
Intermediate Similarity |
NPD1791 |
Approved |
0.7131 |
Intermediate Similarity |
NPD5951 |
Approved |
0.7131 |
Intermediate Similarity |
NPD1793 |
Approved |
0.7122 |
Intermediate Similarity |
NPD7910 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7092 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7087 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7068 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.705 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7049 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7043 |
Intermediate Similarity |
NPD3028 |
Approved |
0.7031 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7031 |
Intermediate Similarity |
NPD3070 |
Discontinued |
0.7031 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7031 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7021 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7021 |
Intermediate Similarity |
NPD2420 |
Approved |
0.7021 |
Intermediate Similarity |
NPD2421 |
Approved |
0.7021 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7016 |
Intermediate Similarity |
NPD7636 |
Approved |
0.7015 |
Intermediate Similarity |
NPD3109 |
Approved |
0.7015 |
Intermediate Similarity |
NPD3110 |
Approved |
0.6992 |
Remote Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.6978 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6978 |
Remote Similarity |
NPD2209 |
Approved |
0.6978 |
Remote Similarity |
NPD2211 |
Approved |
0.6977 |
Remote Similarity |
NPD1669 |
Approved |
0.6972 |
Remote Similarity |
NPD3645 |
Discontinued |
0.6972 |
Remote Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.6963 |
Remote Similarity |
NPD3657 |
Discovery |
0.6953 |
Remote Similarity |
NPD1611 |
Approved |
0.6953 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6947 |
Remote Similarity |
NPD6584 |
Phase 3 |
0.6935 |
Remote Similarity |
NPD709 |
Approved |
0.6929 |
Remote Similarity |
NPD5238 |
Clinical (unspecified phase) |
0.6917 |
Remote Similarity |
NPD7095 |
Approved |
0.6912 |
Remote Similarity |
NPD4579 |
Clinical (unspecified phase) |
0.6906 |
Remote Similarity |
NPD7037 |
Approved |
0.6906 |
Remote Similarity |
NPD4257 |
Approved |
0.6906 |
Remote Similarity |
NPD4256 |
Phase 2 |
0.6894 |
Remote Similarity |
NPD4208 |
Discontinued |
0.6885 |
Remote Similarity |
NPD228 |
Approved |
0.688 |
Remote Similarity |
NPD405 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD1980 |
Approved |
0.6875 |
Remote Similarity |
NPD1981 |
Approved |
0.6875 |
Remote Similarity |
NPD1983 |
Approved |
0.6866 |
Remote Similarity |
NPD2028 |
Clinical (unspecified phase) |
0.6864 |
Remote Similarity |
NPD9608 |
Approved |
0.6864 |
Remote Similarity |
NPD9610 |
Approved |
0.686 |
Remote Similarity |
NPD5451 |
Approved |
0.6857 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6855 |
Remote Similarity |
NPD1476 |
Clinical (unspecified phase) |
0.6809 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.68 |
Remote Similarity |
NPD7157 |
Approved |
0.6797 |
Remote Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.6797 |
Remote Similarity |
NPD2668 |
Approved |
0.6797 |
Remote Similarity |
NPD2667 |
Approved |
0.6794 |
Remote Similarity |
NPD8651 |
Approved |
0.6788 |
Remote Similarity |
NPD2157 |
Approved |
0.6772 |
Remote Similarity |
NPD7741 |
Discontinued |
0.6767 |
Remote Similarity |
NPD4212 |
Discontinued |
0.6765 |
Remote Similarity |
NPD6346 |
Approved |
0.6765 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6761 |
Remote Similarity |
NPD8131 |
Suspended |
0.6742 |
Remote Similarity |
NPD1164 |
Approved |
0.6741 |
Remote Similarity |
NPD7294 |
Phase 1 |
0.6718 |
Remote Similarity |
NPD4659 |
Approved |
0.6718 |
Remote Similarity |
NPD1755 |
Approved |
0.6718 |
Remote Similarity |
NPD6582 |
Phase 2 |
0.6718 |
Remote Similarity |
NPD6583 |
Phase 3 |
0.6716 |
Remote Similarity |
NPD4207 |
Discontinued |
0.6714 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6694 |
Remote Similarity |
NPD9377 |
Approved |
0.6694 |
Remote Similarity |
NPD5535 |
Approved |
0.6694 |
Remote Similarity |
NPD9379 |
Approved |
0.6693 |
Remote Similarity |
NPD7644 |
Approved |
0.6691 |
Remote Similarity |
NPD4108 |
Discontinued |
0.669 |
Remote Similarity |
NPD6090 |
Discontinued |
0.669 |
Remote Similarity |
NPD6273 |
Approved |
0.6667 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6667 |
Remote Similarity |
NPD6387 |
Discontinued |
0.6667
|
Remote Similarity |
NPD4198 |
Discontinued |